Olanzapine may prevent vomiting among patients with moderately emetogenic chemotherapy: JAMA
Written By : Jacinthlyn Sylvia
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-08-22 15:15 GMT | Update On 2024-08-22 15:15 GMT
Grandmother Holds Drip for Injured Grandson in Govt Hospital
Advertisement
A new study published in the Journal of American Medical Association suggests that in patients receiving mildly emetogenic chemotherapy, olanzapine added to the usual dose of dexamethasone, palonosetron, and aprepitant greatly improved the management of nausea and vomiting. In regimens of moderately emetogenic chemotherapy (MEC), either with or without neurokinin-1 receptor antagonists, the function of olanzapine has not been well assessed. Thereby, this study by Vikas Ostwal and colleagues wanted to determine if adding olanzapine to a maintenance of consciousness regimen lowers nausea, vomiting, and the need for nausea rescue drugs in patients with hard malignant tumors.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.